Tag: donanemab
Lilly launches Alzheimer’s drugs in India
Eli Lilly and Company (India) has announced the launch of Lormalzi (donanemab, 350 mg/20 mL IV vial) in India, following marketing authorization from the...
Lilly’s Donanemab gets CDSCO approval
Eli Lilly and Company has announced that the Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization for donanemab (350 mg/20 mL administered...